Skip to main content
Log in

Infections as predictors of NAFLD progression

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sanyal AJ (2019) Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 16:377–386. https://doi.org/10.1038/S41575-019-0144-8

    Article  PubMed  Google Scholar 

  2. Petta S, Marrone O, Torres D et al (2015) Obstructive sleep apnea is associated with liver damage and atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0142210

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wong RJ, Singal AK (2020) Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open. https://doi.org/10.1001/JAMANETWORKOPEN.2019.20294

    Article  PubMed  PubMed Central  Google Scholar 

  4. Diehl AM, Day C (2017) Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 377:2063–2072. https://doi.org/10.1056/NEJMRA1503519

    Article  CAS  PubMed  Google Scholar 

  5. Saitta C, Caruso A, Maimone S et al (2022) Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity. Intern Emerg Med. https://doi.org/10.1007/S11739-022-02971-5

    Article  PubMed  PubMed Central  Google Scholar 

  6. Raimondo G, Saitta C, Lombardo D et al (2020) Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy. Liver Int 40:1601–1609. https://doi.org/10.1111/LIV.14473

    Article  CAS  PubMed  Google Scholar 

  7. Bechmann LP, Hannivoort RA, Gerken G et al (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56:952–964. https://doi.org/10.1016/J.JHEP.2011.08.025

    Article  CAS  PubMed  Google Scholar 

  8. Peiseler M, Schwabe R, Hampe J et al (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J Hepatol. https://doi.org/10.1016/J.JHEP.2022.06.012

    Article  PubMed  Google Scholar 

  9. Raimondo G, Locarnini S, Pollicino T et al (2019) Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 71:397–408. https://doi.org/10.1016/J.JHEP.2019.03.034

    Article  PubMed  Google Scholar 

  10. Mulrooney-Cousins PM, Michalak TI (2007) Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 13:5682–5686. https://doi.org/10.3748/WJG.V13.I43.5682

    Article  PubMed  PubMed Central  Google Scholar 

  11. Raimondo G, Pollicino T, Squadrito G (2005) What is the clinical impact of occult hepatitis B virus infection? Lancet 365:638–640. https://doi.org/10.1016/S0140-6736(05)17961-6

    Article  PubMed  Google Scholar 

  12. Alon L, Corica B, Raparelli V et al (2022) Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol 29:938–946. https://doi.org/10.1093/EURJPC/ZWAB212

    Article  PubMed  Google Scholar 

  13. Pothineni NVK, Subramany S, Kuriakose K et al (2017) Infections, atherosclerosis, and coronary heart disease. Eur Heart J 38:3195–3201. https://doi.org/10.1093/EURHEARTJ/EHX362

    Article  CAS  PubMed  Google Scholar 

  14. Cangemi R, Pignatelli P, Carnevale R et al (2016) Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. J Infect 73:107–114. https://doi.org/10.1016/J.JINF.2016.05.013

    Article  PubMed  Google Scholar 

  15. Carnevale R, Sciarretta S, Valenti V et al (2020) Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J 41:3156–3165. https://doi.org/10.1093/EURHEARTJ/EHZ893

    Article  CAS  PubMed  Google Scholar 

  16. Wang CR, Tsai HW (2021) Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol 27:19–36. https://doi.org/10.3748/WJG.V27.I1.19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Cacoub P, Terrier B (2009) Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am 35:125–137. https://doi.org/10.1016/J.RDC.2009.03.006

    Article  PubMed  Google Scholar 

  18. Mason A, Theal J, Bain V et al (2005) Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am J Gastroenterol 100:972–976. https://doi.org/10.1111/J.1572-0241.2005.41308.X

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefania Basili.

Ethics declarations

Conflict of interest

The authors state that they have no conflict of interests..

Human and animal rights

This article does not contain any studies directly involving human participants or animals.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cangemi, R., Miglionico, M. & Basili, S. Infections as predictors of NAFLD progression. Intern Emerg Med 17, 2185–2186 (2022). https://doi.org/10.1007/s11739-022-03096-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-022-03096-5

Navigation